MedPath

Analgesic Effect Between TAP Block and Continuous Wound Infusion in Abdominoplasty Surgery

Not Applicable
Conditions
Surgery of Abdominoplasty With Flank Liposuction
Interventions
Procedure: Transverse abdominal plan block
Procedure: Continuous wound infusion
Registration Number
NCT01862354
Lead Sponsor
University of Liege
Brief Summary

The purpose of this randomized controlled study is to compare the postoperative analgesic effect of a continuous wound infusion of local anesthetics and a sole transverse abdominal plan (TAP) regional block in the surgery of Abdominoplasty Combined With Flank Liposuction. Local anesthetics products used are ropivacaine combined with clonidine. Similar amount of local anesthetics and clonidine are used.

Detailed Description

In a first group, patients receive, after induction of anaesthesia and before surgery, a TAP block (transverse abdominal plan block) with 3mg/kg Ropivacaine 0.5% (maximum 200 mg) and 150 microg Clonidine.

In a second group, before skin closure, a multiholes catheter was inserted beyond the skin. 20 mg Ropivacaine 0.2% added with 150 microg Clonidine was injected as bolus dose through this catheter followed by a continuous infusion of Ropivacaine 0.2% 10ml per hour during the following 9 hours (total dose of 200 mgr).

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
50
Inclusion Criteria
  • Patients scheduled for abdominoplasty combined with flank liposuction
Exclusion Criteria
  • Allergy to local anesthetics or clonidine
  • Coagulation disorders
  • History of chronic pain
  • Alcohol or drugs dependance
  • Refusal of the patients

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Group TAP blockTransverse abdominal plan blockPatients in this group received a transverse abdominal plan block with local anesthetics and clonidine as postoperative analgesia.
Group : Continuous wound infusionContinuous wound infusionPatients in this group received continuous wound infusion with local anesthetics and clonidine as postoperative analgesia.
Primary Outcome Measures
NameTimeMethod
Pain score expressed on a visual analogue scaleat 0,2,4,6, 8 hours, and day 1 and day 2 postoperatively
Secondary Outcome Measures
NameTimeMethod
Piritramide consumption on Patient Controlled Analgesia (PCA) deviceat 0,2,4,6, 8 hours, and day 1 and day 2 postoperatively
Scale of nauseaat 0,2,4,6, 8 hours, and day 1 and day 2 postoperatively

Scale of nausea was defined as :

0 = No nausea - 1 = weak nausea - 2 = Moderate nausea - 3 = Important nausea

Scale of sedationat 0,2,4,6, 8 hours, and day 1 and day 2 postoperatively

Scale of sedation was defined as :

0 = Awake patient - 1 = Quiet and awake - 2 = Sleepy but arousable - 3 = Sleepy and not arousable

Scale of patient's satisfactionat day 2 postoperatively

Scale of satisfaction was defined as :

1 = Very satisfied - 2 = Satisfied with no enthusiasm - 3 = Not satisfied

Number of patients with adverse eventsdaily during 48 hours postoperatively

Trial Locations

Locations (1)

University of Liege, University Hospital

🇧🇪

Liege, Belgium

© Copyright 2025. All Rights Reserved by MedPath